logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Pliant Therapeutics, Inc.


USPTO Granted Patents = 16


Trademarks = 1

Forward Citations = 105

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Jacob Cha (13 out of 13 patents)

silverMedal Timothy Hom (9 out of 9 patents)

bronzeMedal David John Morgans, Jr (9 out of 101 patents)

4.  Katerina Leftheris (8 out of 90 patents)

5.  Hui Li (7 out of 142 patents)

6.  Lan Jiang (7 out of 64 patents)

7.  Maureen Kay Reilly (6 out of 24 patents)

8.  Gustave Bergnes (5 out of 63 patents)

9.  Randall Halcomb (5 out of 46 patents)

10.  Nicole Cooper (4 out of 4 patents)

11.  Christopher Bailey (4 out of 5 patents)

12.  Yajun Zheng (4 out of 38 patents)

13.  Darren Finkelstein (3 out of 3 patents)

14.  Manuel Munoz (3 out of 6 patents)

15.  Patrick Andre (3 out of 18 patents)


16 patents:

1. 12637462 - Integrin inhibitor and uses thereof (2026-05-26),
2. RE50554 - Amino acid compounds and methods of use (2025-08-26),
3. 12390463 - Dosage forms and regimens for amino acid compounds (2025-08-19),
4. 12134642 - Antibodies binding to α7β1 integrin antibodies and compositions thereof (2024-11-05),
5. 12018025 - Integrin inhibitor and uses thereof (2024-06-25),
6. 11952376 - Substituted amino acids as integrin inhibitors (2024-04-09),
7. 11858931 - Amino acid compounds with unbranched linkers and methods of use (2024-01-02),
8. 11673887 - N-acyl amino acid compounds and methods of use (2023-06-13),
9. 11634418 - Amino acid compounds and methods of use (2023-04-25),
10. 11560376 - Amino acid compounds and methods of use (2023-01-24),
11. 11419869 - Dosage forms and regimens for amino acid compounds (2022-08-23),
12. 11396506 - Amino acid compounds with unbranched linkers and methods of use (2022-07-26),
13. 11180494 - Substituted amino acids as integrin inhibitors (2021-11-23),
14. 10793564 - Amino acid compounds and methods of use (2020-10-06),
15. 10696672 - Amino acid compounds and methods of use (2020-06-30),
Company Overview
Pliant Therapeutics, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for fibrotic diseases. The company specializes in harnessing its proprietary drug discovery platform to identify and advance novel small molecule therapeutics that target the underlying mechanisms of fibrosis. With a commitment to addressing unmet medical needs, Pliant aims to improve patient outcomes through its research in the field of fibrosis and related conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Pliant Therapeutics, Inc. USPTO Patent Assignee Logo
16 Patents

#79 in South San Francisco, CA

#4,770 in California

#19,922 in US

#37,831 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Pliant Therapeutics, Inc.

Forward Citations = 105

25 inventors:

goldMedal Jacob Cha (13 out of 13 patents)

silverMedal Timothy Hom (9 out of 9 patents)

bronzeMedal David John Morgans, Jr (9 out of 101 patents)

4.  Katerina Leftheris (8 out of 90 patents)

5.  Hui Li (7 out of 142 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pliant Therapeutics, Inc.. Retrieved from https://idiyas.com/company/pliant-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…